-+ 0.00%
-+ 0.00%
-+ 0.00%

PEPTIDREAM ANNOUNCES PROMISING PRE-CLINICAL RESULTS OF PROPRIETARY ORAL IL-17A AND IL-17F DUAL INHIBITOR WITH BIOLOGIC-LIKE EFFICACY FOR THE TREATMENT OF PSORIASIS

Reuters·12/17/2025 13:00:03

Please log in to view news